{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T01:02:31Z","timestamp":1781830951316,"version":"3.54.5"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T00:00:00Z","timestamp":1737590400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T00:00:00Z","timestamp":1737590400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"NTNU Norwegian University of Science and Technology"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Enteroviruses can infect various human organs, causing diseases such as meningitis, the common cold, hand-foot-and-mouth disease, myocarditis, pancreatitis, hepatitis, poliomyelitis, sepsis, and type 1 diabetes. Currently, there are no approved treatments for enterovirus infections. In this study, we identified a synergistic combination of orally available, safe-in-man pleconaril, AG7404, and mindeudesivir, that at non-toxic concentrations effectively inhibited enterovirus replication in human cell and organoid cultures. Importantly, the cocktail did not alter glucose and insulin levels in the culture medium of pancreatic \u03b2-cells and preserved the contraction rhythm of infected heart organoids. These findings highlight a promising drug cocktail for further preclinical studies and clinical trials targeting a broad range of enterovirus-mediated diseases.<\/jats:p>","DOI":"10.1007\/s00018-025-05581-4","type":"journal-article","created":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T02:51:01Z","timestamp":1737600661000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Synergistic combination of orally available safe-in-man pleconaril, AG7404, and mindeudesivir inhibits enterovirus infections in human cell and organoid cultures"],"prefix":"10.1007","volume":"82","author":[{"given":"Erlend","family":"Ravlo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandr","family":"Ianevski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f8rn-Ove","family":"Schj\u00f8lberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Solvang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rabina","family":"Dumaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilde","family":"Lysvand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Hankinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"V\u00e4h\u00e4-Koskela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanna","family":"Vainionp\u00e4\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anni","family":"Varhe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Sepp\u00e4nen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teemu","family":"Smura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yining","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengfei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuwei","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Knut","family":"Dahl-Jorgensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Krogvold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oleksandr","family":"Kamyshnyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Johnny Schjelderup","family":"Nilsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inger Johanne","family":"Haugen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erling","family":"H\u00f8yer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Egil","family":"Afset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentyn","family":"Oksenych","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angel S.","family":"Galabov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adelina","family":"Stoyanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"van Loon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Lulla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnar","family":"Bj\u00f8r\u00e5s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7716-6955","authenticated-orcid":false,"given":"Denis E.","family":"Kainov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,23]]},"reference":[{"key":"5581_CR1","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/s41579-018-0005-4","volume":"16","author":"J Baggen","year":"2018","unstructured":"Baggen J et al (2018) The life cycle of non-polio enteroviruses and how to target it. Nat Rev Microbiol 16:368\u2013381. https:\/\/doi.org\/10.1038\/s41579-018-0005-4","journal-title":"Nat Rev Microbiol"},{"key":"5581_CR2","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1038\/s41591-019-0667-0","volume":"25","author":"K Vehik","year":"2019","unstructured":"Vehik K et al (2019) Prospective virome analyses in young children at increased genetic risk for type 1 diabetes. Nat Med 25:1865\u20131872. https:\/\/doi.org\/10.1038\/s41591-019-0667-0","journal-title":"Nat Med"},{"key":"5581_CR3","doi-asserted-by":"publisher","unstructured":"Alhazmi A et al (2020) Enteroviruses and type 1 diabetes Mellitus: an overlooked relationship in some regions. Microorganisms 8. https:\/\/doi.org\/10.3390\/microorganisms8101458","DOI":"10.3390\/microorganisms8101458"},{"key":"5581_CR4","doi-asserted-by":"publisher","unstructured":"Grapin M et al (2023) Severe and fatal neonatal infections linked to a new variant of echovirus 11, France, July 2022 to April 2023. Euro Surveill 28. https:\/\/doi.org\/10.2807\/1560-7917.ES.2023.28.22.2300253","DOI":"10.2807\/1560-7917.ES.2023.28.22.2300253"},{"key":"5581_CR5","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3201\/eid3002.231024","volume":"30","author":"NVV Chau","year":"2024","unstructured":"Chau NVV et al (2024) Emerging Enterovirus A71 Subgenogroup B5 causing severe Hand, Foot, and Mouth Disease, Vietnam, 2023. Emerg Infect Dis 30:363\u2013367. https:\/\/doi.org\/10.3201\/eid3002.231024","journal-title":"Emerg Infect Dis"},{"key":"5581_CR6","doi-asserted-by":"publisher","first-page":"e29194","DOI":"10.1002\/jmv.29194","volume":"95","author":"K Coudere","year":"2023","unstructured":"Coudere K et al (2023) First description and phylogenetic analysis of coxsackie virus a non-polio enteroviruses and parechoviruses a in South Sudanese children. J Med Virol 95:e29194. https:\/\/doi.org\/10.1002\/jmv.29194","journal-title":"J Med Virol"},{"key":"5581_CR7","unstructured":"(2024) About Non-Polio Enteroviruses"},{"key":"5581_CR8","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.apsb.2021.08.017","volume":"12","author":"J Wang","year":"2022","unstructured":"Wang J et al (2022) Enterovirus A71 antivirals: past, present, and future. Acta Pharm Sin B 12:1542\u20131566. https:\/\/doi.org\/10.1016\/j.apsb.2021.08.017","journal-title":"Acta Pharm Sin B"},{"key":"5581_CR9","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jare.2023.03.007","volume":"56","author":"S Wang","year":"2024","unstructured":"Wang S et al (2024) Advances in anti-EV-A71 drug development research. J Adv Res 56:137\u2013156. https:\/\/doi.org\/10.1016\/j.jare.2023.03.007","journal-title":"J Adv Res"},{"key":"5581_CR10","doi-asserted-by":"publisher","unstructured":"Roux H et al (2024) From the One Molecule\u2013 One Target\u2013 One Disease Concept towards Looking for Multi-target Therapeutics for Treating Non-polio Enterovirus (Npev) Infections. Preprints. https:\/\/doi.org\/10.20944\/preprints202407.1270.v1","DOI":"10.20944\/preprints202407.1270.v1"},{"key":"5581_CR11","doi-asserted-by":"publisher","unstructured":"Ianevski A et al (2020) Identification and Tracking of Antiviral Drug combinations. Viruses 12. https:\/\/doi.org\/10.3390\/v12101178","DOI":"10.3390\/v12101178"},{"key":"5581_CR12","doi-asserted-by":"publisher","unstructured":"White JM et al (2021) Drug Combinations as a First Line of Defense against Coronaviruses and Other Emerging Viruses. mBio 12, e0334721. https:\/\/doi.org\/10.1128\/mbio.03347-21","DOI":"10.1128\/mbio.03347-21"},{"key":"5581_CR13","doi-asserted-by":"publisher","first-page":"105842","DOI":"10.1016\/j.antiviral.2024.105842","volume":"224","author":"A Ianevski","year":"2024","unstructured":"Ianevski A et al (2024) The combination of pleconaril, rupintrivir, and remdesivir efficiently inhibits enterovirus infections in vitro, delaying the development of drug-resistant virus variants. Antiviral Res 224:105842. https:\/\/doi.org\/10.1016\/j.antiviral.2024.105842","journal-title":"Antiviral Res"},{"key":"5581_CR14","doi-asserted-by":"publisher","first-page":"105458","DOI":"10.1016\/j.antiviral.2022.105458","volume":"208","author":"M Fabrega-Ferrer","year":"2022","unstructured":"Fabrega-Ferrer M et al (2022) Structure and inhibition of SARS-CoV-1 and SARS-CoV-2 main proteases by oral antiviral compound AG7404. Antiviral Res 208:105458. https:\/\/doi.org\/10.1016\/j.antiviral.2022.105458","journal-title":"Antiviral Res"},{"key":"5581_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(23)00577-7","author":"X Fan","year":"2023","unstructured":"Fan X et al (2023) Oral VV116 versus placebo in patients with mild-to-moderate COVID-19 in China: a multicentre, double-blind, phase 3, randomised controlled study. Lancet Infect Dis. https:\/\/doi.org\/10.1016\/S1473-3099(23)00577-7","journal-title":"Lancet Infect Dis"},{"key":"5581_CR16","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1086\/375069","volume":"36","author":"FG Hayden","year":"2003","unstructured":"Hayden FG et al (2003) Efficacy and safety of oral pleconaril for treatment of colds due to picornaviruses in adults: results of 2 double-blind, randomized, placebo-controlled trials. Clin Infect Dis 36:1523\u20131532. https:\/\/doi.org\/10.1086\/375069","journal-title":"Clin Infect Dis"},{"key":"5581_CR17","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S1473-3099(23)00577-7","volume":"24","author":"X Fan","year":"2024","unstructured":"Fan X et al (2024) Oral VV116 versus placebo in patients with mild-to-moderate COVID-19 in China: a multicentre, double-blind, phase 3, randomised controlled study. Lancet Infect Dis 24:129\u2013139. https:\/\/doi.org\/10.1016\/S1473-3099(23)00577-7","journal-title":"Lancet Infect Dis"},{"key":"5581_CR18","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.jviromet.2005.05.005","volume":"128","author":"S Biacchesi","year":"2005","unstructured":"Biacchesi S et al (2005) Rapid human metapneumovirus microneutralization assay based on green fluorescent protein expression. J Virol Methods 128:192\u2013197. https:\/\/doi.org\/10.1016\/j.jviromet.2005.05.005","journal-title":"J Virol Methods"},{"key":"5581_CR19","doi-asserted-by":"publisher","first-page":"11714","DOI":"10.1038\/s41598-023-38743-0","volume":"13","author":"E Ravlo","year":"2023","unstructured":"Ravlo E et al (2023) A fast, low-cost, robust and high-throughput method for viral nucleic acid isolation based on NAxtra magnetic nanoparticles. Sci Rep 13:11714. https:\/\/doi.org\/10.1038\/s41598-023-38743-0","journal-title":"Sci Rep"},{"key":"5581_CR20","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402\u2013408. https:\/\/doi.org\/10.1006\/meth.2001.1262","journal-title":"Methods"},{"key":"5581_CR21","doi-asserted-by":"publisher","unstructured":"Ianevski A et al (2022) Novel synergistic Anti-enteroviral Drug combinations. Viruses 14. https:\/\/doi.org\/10.3390\/v14091866","DOI":"10.3390\/v14091866"},{"key":"5581_CR22","doi-asserted-by":"publisher","first-page":"3602","DOI":"10.1093\/bioinformatics\/btaa138","volume":"36","author":"S Potdar","year":"2020","unstructured":"Potdar S et al (2020) Breeze: an integrated quality control and data analysis application for high-throughput drug screening. Bioinformatics 36:3602\u20133604. https:\/\/doi.org\/10.1093\/bioinformatics\/btaa138","journal-title":"Bioinformatics"},{"key":"5581_CR23","doi-asserted-by":"publisher","first-page":"5193","DOI":"10.1038\/srep05193","volume":"4","author":"B Yadav","year":"2014","unstructured":"Yadav B et al (2014) Quantitative scoring of differential drug sensitivity for individually optimized anticancer therapies. Sci Rep 4:5193. https:\/\/doi.org\/10.1038\/srep05193","journal-title":"Sci Rep"},{"key":"5581_CR24","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkac382","author":"A Ianevski","year":"2022","unstructured":"Ianevski A et al (2022) SynergyFinder 3.0: an interactive analysis and consensus interpretation of multi-drug synergies across multiple samples. Nucleic Acids Res. https:\/\/doi.org\/10.1093\/nar\/gkac382","journal-title":"Nucleic Acids Res"},{"key":"5581_CR25","doi-asserted-by":"publisher","unstructured":"Makinen L et al (2022) Pancreatic Cancer organoids in the field of Precision Medicine: a review of literature and experience on drug sensitivity testing with multiple readouts and synergy scoring. Cancers (Basel) 14. https:\/\/doi.org\/10.3390\/cancers14030525","DOI":"10.3390\/cancers14030525"},{"key":"5581_CR26","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.cell.2014.12.021","volume":"160","author":"SF Boj","year":"2015","unstructured":"Boj SF et al (2015) Organoid models of human and mouse ductal pancreatic cancer. Cell 160:324\u2013338. https:\/\/doi.org\/10.1016\/j.cell.2014.12.021","journal-title":"Cell"},{"key":"5581_CR27","doi-asserted-by":"publisher","first-page":"102725","DOI":"10.1016\/j.xpro.2023.102725","volume":"4","author":"B Al-Mhanawi","year":"2023","unstructured":"Al-Mhanawi B et al (2023) Protocol for generating embedding-free brain organoids enriched with oligodendrocytes. STAR Protoc 4:102725. https:\/\/doi.org\/10.1016\/j.xpro.2023.102725","journal-title":"STAR Protoc"},{"key":"5581_CR28","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.reth.2021.12.003","volume":"19","author":"S Yamasaki","year":"2022","unstructured":"Yamasaki S et al (2022) Addition of Chk1 inhibitor and BMP4 cooperatively promotes retinal tissue formation in self-organizing human pluripotent stem cell differentiation culture. Regen Ther 19:24\u201334. https:\/\/doi.org\/10.1016\/j.reth.2021.12.003","journal-title":"Regen Ther"},{"key":"5581_CR29","doi-asserted-by":"publisher","first-page":"3299","DOI":"10.1016\/j.cell.2021.04.034","volume":"184","author":"P Hofbauer","year":"2021","unstructured":"Hofbauer P et al (2021) Cardioids reveal self-organizing principles of human cardiogenesis. Cell 184:3299\u20133317e3222. https:\/\/doi.org\/10.1016\/j.cell.2021.04.034","journal-title":"Cell"},{"key":"5581_CR30","doi-asserted-by":"publisher","first-page":"100044","DOI":"10.1016\/j.crmeth.2021.100044","volume":"1","author":"S Scalzo","year":"2021","unstructured":"Scalzo S et al (2021) Dense optical flow software to quantify cellular contractility. Cell Rep Methods 1:100044. https:\/\/doi.org\/10.1016\/j.crmeth.2021.100044","journal-title":"Cell Rep Methods"},{"key":"5581_CR31","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkac348","author":"A Ianevski","year":"2022","unstructured":"Ianevski A et al (2022) DrugVirus.info 2.0: an integrative data portal for broad-spectrum antivirals (BSA) and BSA-containing drug combinations (BCCs). Nucleic Acids Res. https:\/\/doi.org\/10.1093\/nar\/gkac348","journal-title":"Nucleic Acids Res"},{"key":"5581_CR32","doi-asserted-by":"publisher","first-page":"1326711","DOI":"10.3389\/fimmu.2023.1326711","volume":"14","author":"JRN Lemos","year":"2023","unstructured":"Lemos JRN et al (2023) Immunological and virological triggers of type 1 diabetes: insights and implications. Front Immunol 14:1326711. https:\/\/doi.org\/10.3389\/fimmu.2023.1326711","journal-title":"Front Immunol"},{"key":"5581_CR33","doi-asserted-by":"publisher","first-page":"2902","DOI":"10.1038\/s41591-023-02576-1","volume":"29","author":"L Krogvold","year":"2023","unstructured":"Krogvold L et al (2023) Pleconaril and Ribavirin in new-onset type 1 diabetes: a phase 2 randomized trial. Nat Med 29:2902\u20132908. https:\/\/doi.org\/10.1038\/s41591-023-02576-1","journal-title":"Nat Med"},{"key":"5581_CR34","doi-asserted-by":"publisher","first-page":"101772","DOI":"10.1016\/j.molmet.2023.101772","volume":"76","author":"B Blanchi","year":"2023","unstructured":"Blanchi B et al (2023) EndoC-betaH5 cells are storable and ready-to-use human pancreatic beta cells with physiological insulin secretion. Mol Metab 76:101772. https:\/\/doi.org\/10.1016\/j.molmet.2023.101772","journal-title":"Mol Metab"},{"key":"5581_CR35","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1038\/s12276-021-00629-4","volume":"53","author":"C Aguilar","year":"2021","unstructured":"Aguilar C et al (2021) Organoids as host models for infection biology - a review of methods. Exp Mol Med 53:1471\u20131482. https:\/\/doi.org\/10.1038\/s12276-021-00629-4","journal-title":"Exp Mol Med"},{"key":"5581_CR36","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1203\/00006450-199904020-01026","volume":"45","author":"J Romero","year":"1999","unstructured":"Romero J et al (1999) Pleconaril Treatment of Vaccine-Acquired Poliovirus. Pediatr Res 45:173. https:\/\/doi.org\/10.1203\/00006450-199904020-01026","journal-title":"Pediatr Res"},{"key":"5581_CR37","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1097\/01.inf.0000059765.92623.70","volume":"22","author":"MJ Abzug","year":"2003","unstructured":"Abzug MJ et al (2003) Double blind placebo-controlled trial of pleconaril in infants with enterovirus meningitis. Pediatr Infect Dis J 22:335\u2013341. https:\/\/doi.org\/10.1097\/01.inf.0000059765.92623.70","journal-title":"Pediatr Infect Dis J"},{"key":"5581_CR38","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1093\/jpids\/piv015","volume":"5","author":"MJ Abzug","year":"2016","unstructured":"Abzug MJ et al (2016) A Randomized, Double-Blind, placebo-controlled trial of Pleconaril for the treatment of neonates with Enterovirus Sepsis. J Pediatr Infect Dis Soc 5:53\u201362. https:\/\/doi.org\/10.1093\/jpids\/piv015","journal-title":"J Pediatr Infect Dis Soc"},{"key":"5581_CR39","doi-asserted-by":"publisher","unstructured":"Zhang R et al (2022) Oral remdesivir derivative VV116 is a potent inhibitor of respiratory syncytial virus with efficacy in mouse model. Signal Transduct Target Ther 7. https:\/\/doi.org\/10.1038\/s41392-022-00963-7","DOI":"10.1038\/s41392-022-00963-7"},{"key":"5581_CR40","doi-asserted-by":"publisher","unstructured":"Liu W et al (2023) Remdesivir Derivative VV116 is a potential broad-spectrum inhibitor of both human and animal coronaviruses. Viruses 15. https:\/\/doi.org\/10.3390\/v15122295","DOI":"10.3390\/v15122295"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-025-05581-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00018-025-05581-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-025-05581-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T02:51:09Z","timestamp":1737600669000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00018-025-05581-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,23]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5581"],"URL":"https:\/\/doi.org\/10.1007\/s00018-025-05581-4","relation":{},"ISSN":["1420-9071"],"issn-type":[{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,23]]},"assertion":[{"value":"25 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study involved commercially available human cell lines, WT virus strains, which we isolated from patient samples or obtained via collaborations. All experiments with viruses were performed in BSL2 laboratories in compliance with the guidelines of the national authorities, and under appropriate ethical and safety approvals. All experiments conducted with pancreatic cancer organoids have been approved by the Helsinki University Hospital ethical board, HUS\/74\/2023, HUS\/23\/2024. The Medical Ethical Committee of the Erasmus MC Rotterdam granted permission for study on lung organoids (METC 2012\u2009\u2212\u2009512).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"57"}}